Related references
Note: Only part of the references are listed.Stem cell marker CD133 affects clinical outcome in glioma patients
Felix Zeppernick et al.
CLINICAL CANCER RESEARCH (2008)
Neuroprotection by Imipramine against lipopolysaccharide-induced apoptosis in hippocampus-derived neural stem cells mediated by activation of BDNF and the MAPK pathway
Chi-Hsien Peng et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
2-Methoxyestradiol attenuates phosphatidylinositol 3-kinase/Akt pathway-mediated metastasis of gastric cancer
Heng-Liang Lin et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
CD133+ and CD133- glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles
Dagmar Beier et al.
CANCER RESEARCH (2007)
Tumour-initiating cells vs. cancer 'stem' cells and CD133: What's in the name?
Jiri Neuzil et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Induction and loss of a TP53-dependent radioadaptive response in the human lymphoblastoid cell model TK6 and its abrogation by BCL2 over-expression
Jeffrey L. Schwartz et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2007)
Overexpression of NBS1 induces epithelial-mesenchymal transition and co-expression of NBS1 and Snail predicts metastasis of head and neck cancer
M-H Yang et al.
ONCOGENE (2007)
Identification and expansion of human colon-cancer-initiating cells
Lucia Ricci-Vitiani et al.
NATURE (2007)
Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia
Ed R. Blazek et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation
Aaheli Roy Choudhury et al.
NATURE GENETICS (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Regulating the p53 pathway:: in vitro hypotheses, in vivo veritas
Franck Toledo et al.
NATURE REVIEWS CANCER (2006)
Relationship between DNA double-strand break rejoining and cell survival after exposure to ionizing radiation in human fibroblast strains with differing ATM/p53 status: Implications for evaluation of clinical radiosensitivity
Razmik Mirzayans et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
The immediate early 2 protein of human cytomegalovirus (HCMV) mediates the apoptotic control in HCMV retinitis through up-regulation of the cellular FLICE-inhibitory protein expression
Shih-Hwa Chiou et al.
JOURNAL OF IMMUNOLOGY (2006)
Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells
Wenrui Duan et al.
EXPERIMENTAL CELL RESEARCH (2006)
ATM activation is accompanied with earlier stages of prostate tumorigenesis
Catherine Fan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2006)
The ATM-mediated DNA-damage response: taking shape
Yosef Shiloh
TRENDS IN BIOCHEMICAL SCIENCES (2006)
Moclobemide upregulated Bcl-2 expression and induced neural stem cell differentiation into serotoninergic neuron via extracellular-regulated kinase pathway
Shih-Hwa Chiou et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Primary pediatric brain tumors - Statistics of Taipei VGH, Taiwan (1975-2004)
TT Wong et al.
CANCER (2005)
Bcl-2 expression predicts radiotherapy failure in laryngeal cancer
P Nix et al.
BRITISH JOURNAL OF CANCER (2005)
The transcriptional targets of p53 in apoptosis control
J Yu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Increased expression of osteopontin gene in atypical teratoid/rhabdoid tumor of the central nervous system
CL Kao et al.
MODERN PATHOLOGY (2005)
ATM regulates target switching to escalating doses of radiation in the intestines
HJ Ch'ang et al.
NATURE MEDICINE (2005)
Atypical teratoid/rhabdoid tumor of the brain - Cytopathologic characteristics and differential diagnosis
AV Parwani et al.
CANCER CYTOPATHOLOGY (2005)
Atypical teratoid/rhabdoid tumors (ATRT): Improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy
TM Tekautz et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Neuroradiological findings in atypical teratoid/rhabdoid tumor of the central nervous system
YC Cheng et al.
ACTA RADIOLOGICA (2005)
Central nervous system atypical teratoid/rhabdoid tumor: Results of therapy in children enrolled in a registry
JM Hilden et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
Cancerous stem cells can arise from pediatric brain tumors
HD Hemmati et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Atypical teratoid/rhabdoid tumor of the central nervous system: Report on workshop
RJ Packer et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2002)
Prediction of central nervous system embryonal tumour outcome based on gene expression
SL Pomeroy et al.
NATURE (2002)
Atypical teratoid/rhabdoid tumor of the central nervous system: a comparative study with primitive neuroectodermal tumor/medulloblastoma
DMT Ho et al.
ACTA NEUROPATHOLOGICA (2000)
Share Paper
